Title
Zscan4 Inhibits Maintenance DNA Methylation to Facilitate Telomere Elongation in Mouse Embryonic Stem Cells
Date Issued
22 August 2017
Access level
open access
Resource Type
journal article
Author(s)
Dan J.
Rousseau P.
Hardikar S.
Wong J.
Autexier C.
Chen T.
The University of Texas MD Anderson Cancer Center
Publisher(s)
Elsevier B.V.
Abstract
Proper telomere length is essential for embryonic stem cell (ESC) self-renewal and pluripotency. Mouse ESCs (mESCs) sporadically convert to a transient totipotent state similar to that of two-cell (2C) embryos to recover shortened telomeres. Zscan4, which exhibits a burst of expression in 2C-like mESCs, is required for telomere extension in these cells. However, the mechanism by which Zscan4 extends telomeres remains elusive. Here, we show that Zscan4 facilitates telomere elongation by inducing global DNA demethylation through downregulation of Uhrf1 and Dnmt1, major components of the maintenance DNA methylation machinery. Mechanistically, Zscan4 recruits Uhrf1 and Dnmt1 and promotes their degradation, which depends on the E3 ubiquitin ligase activity of Uhrf1. Blocking DNA demethylation prevents telomere elongation associated with Zscan4 expression, suggesting that DNA demethylation mediates the effect of Zscan4. Our results define a molecular pathway that contributes to the maintenance of telomere length homeostasis in mESCs.
Start page
1936
End page
1949
Volume
20
Issue
8
Language
English
OCDE Knowledge area
Bioquímica, Biología molecular Genética, Herencia
Scopus EID
2-s2.0-85028344733
PubMed ID
Source
Cell Reports
ISSN of the container
22111247
Sponsor(s)
National Institutes of Health - MOP133449 National Institute of Allergy and Infectious Diseases - R01AI121403-NIAID Yale Cancer Center Canadian Institutes of Health Research Cancer Research UK Competence Center Environment and Sustainability T.C. stanbul Kltr niversitesi We thank P. Whitney for technical assistance and P. Lansdorp for help with the TFL-TELO software. This work is supported by a Rising Star Award ( R1108 , to T.C.) from the Cancer Prevention and Research Institute of Texas (CPRIT), a grant ( 1R01AI121403-01A1 , to T.C.) from the NIH , and a grant ( MOP133449 , to C.A.) from the Canadian Institute for Health Research (CIHR). J.D. is supported by a scholarship from the Center for Cancer Epigenetics (CCE) at The University of Texas MD Anderson Cancer Center. N.V. is supported by scholarships from CCE and CPRIT ( RP140106 ). T.C. is a CPRIT Scholar in Cancer Research.
Sources of information: Directorio de Producción Científica Scopus